Literature DB >> 27059871

A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America.

Fan Yu1, Yali Du2, Bing Han3.   

Abstract

To accurately analyze the clinical characteristics of paroxysmal nocturnal hemoglobinuria (PNH) in different ethnic backgrounds, we retrieved all retrospective studies on clinical characteristics of PNH with a median follow-up period >60 months published after 2000, analyzed the clinical characteristics of PNH patients in Asia and European/America, and statistically compared enumeration data in these studies. We included 1665 patients in this analysis. The proportion of female patients in Asia was significantly lower than that in Europe/America (P = 0.000). Incidence rates of hemoglobinuria and thromboembolism in Asia were significantly lower than in Europe/America (both P values were 0.000). Within the subgroups of patients with thromboembolism, Asian patients had a higher proportion of arterial thrombosis while Western patients had a higher proportion of abdominal venous thrombosis. Bone marrow failure was not clearly defined in most studies. The proportion of patients with pancytopenia was higher in China than in France (P = 0.048). The total death rates were similar in both ethnic groups (P > 0.05). In Europe/America the major cause of death was thromboembolism and in Asian countries was serious infections. Differences in population characteristics of PNH patients among different ethnic groups indicate the possibility of differential pathogenesis and may be informative for treatment decisions.

Entities:  

Keywords:  Cytopenia; Intravascular hemolysis; Paroxysmal nocturnal hemoglobinuria; Thrombosis

Mesh:

Year:  2016        PMID: 27059871     DOI: 10.1007/s12185-016-1995-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  29 in total

1.  Clinical features and prognostic factors of Asian patients with paroxysmal nocturnal hemoglobinuria: results from a single center in China.

Authors:  Meili Ge; Xingxin Li; Jun Shi; Yingqi Shao; Yizhou Zheng
Journal:  Ann Hematol       Date:  2012-01-28       Impact factor: 3.673

2.  Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan.

Authors:  Jun-Ichi Nishimura; Yuzuru Kanakura; Russell E Ware; Tsutomu Shichishima; Hideki Nakakuma; Haruhiko Ninomiya; Carlos M Decastro; Sharon Hall; Akihisa Kanamaru; Keith M Sullivan; Hideaki Mizoguchi; Mitsuhiro Omine; Taroh Kinoshita; Wendell F Rosse
Journal:  Medicine (Baltimore)       Date:  2004-05       Impact factor: 1.889

3.  Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays.

Authors:  Victor M Moyo; Galina L Mukhina; Elizabeth S Garrett; Robert A Brodsky
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

4.  Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories.

Authors:  Régis Peffault de Latour; Jean Yves Mary; Célia Salanoubat; Louis Terriou; Gabriel Etienne; Mohamad Mohty; Sophie Roth; Sophie de Guibert; Sebastien Maury; Jean Yves Cahn; Gerard Socié
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

5.  The long-term course of cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; R Sibley; L Newton; S J Tomlanovich; C Boshkos; E Stinson; J A Luetscher; D J Whitney; D Krasny; N S Coplon
Journal:  Kidney Int       Date:  1988-02       Impact factor: 10.612

6.  Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial.

Authors:  Yuzuru Kanakura; Kazuma Ohyashiki; Tsutomu Shichishima; Shinichiro Okamoto; Kiyoshi Ando; Haruhiko Ninomiya; Tatsuya Kawaguchi; Shinji Nakao; Hideki Nakakuma; Jun-ichi Nishimura; Taroh Kinoshita; Camille L Bedrosian; Keiya Ozawa; Mitsuhiro Omine
Journal:  Int J Hematol       Date:  2013-08-11       Impact factor: 2.490

7.  Natural history of paroxysmal nocturnal hemoglobinuria.

Authors:  P Hillmen; S M Lewis; M Bessler; L Luzzatto; J V Dacie
Journal:  N Engl J Med       Date:  1995-11-09       Impact factor: 91.245

8.  Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky; Neal S Young; Elisabetta Antonioli; Antonio M Risitano; Hubert Schrezenmeier; Jörg Schubert; Anna Gaya; Luke Coyle; Carlos de Castro; Chieh-Lin Fu; Jaroslaw P Maciejewski; Monica Bessler; Henk-André Kroon; Russell P Rother; Peter Hillmen
Journal:  Blood       Date:  2007-11-30       Impact factor: 22.113

9.  Paroxysmal nocturnal hemoglobinuria clone in 103 Brazilian patients: diagnosis and classification.

Authors:  Ana Paula de Azambuja; Mariester Malvezzi; Marco Antonio Bitencourt; Michel Michels Oliveira; Larissa Alessandra Medeiros; Ricardo Pasquini
Journal:  Rev Bras Hematol Hemoter       Date:  2015-01-30

10.  Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria.

Authors:  Peter Hillmen; Petra Muus; Alexander Röth; Modupe O Elebute; Antonio M Risitano; Hubert Schrezenmeier; Jeffrey Szer; Paul Browne; Jaroslaw P Maciejewski; Jörg Schubert; Alvaro Urbano-Ispizua; Carlos de Castro; Gérard Socié; Robert A Brodsky
Journal:  Br J Haematol       Date:  2013-04-25       Impact factor: 6.998

View more
  8 in total

1.  Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Masatoshi Sakurai; Jun Ho Jang; Wen-Chien Chou; Jin Seok Kim; Amanda Wilson; Jun-Ichi Nishimura; Tzeon-Jye Chiou; Yuzuru Kanakura; Jong Wook Lee; Shinichiro Okamoto
Journal:  Int J Hematol       Date:  2019-07-05       Impact factor: 2.490

2.  Paroxysmal nocturnal haemoglobinuria, diagnosis and haematological findings, first report from Iran, model for developing countries.

Authors:  Mohammadali Jahangirpour; Amirali Vahedi; Hamed Baghdadi; Tahereh Madani; Ali Behvarmanesh; Mohammad Alidadi; Mohadese Hashem Boroojerdi; Saba Mohammaei; Peyvand Poopak; Amirhossein Poopak; Gelareh Khosravi Pour; Behzad Poopak
Journal:  EJHaem       Date:  2022-03-08

Review 3.  Paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Amy E DeZern; Taroh Kinoshita; Robert A Brodsky
Journal:  Nat Rev Dis Primers       Date:  2017-05-18       Impact factor: 52.329

4.  Clinico-Hematological Profile of Paroxysmal Nocturnal Hemoglobinuria in Indian Patients: FLAER Flow Cytometry Based Experience from an Indian Tertiary Care Centre.

Authors:  Priyanka Mishra; Preeti Tripathi; Rohan Halder; Renu Saxena; Seema Tyagi; Manoranjan Mahapatra; H P Pati
Journal:  Indian J Hematol Blood Transfus       Date:  2020-06-10       Impact factor: 0.900

5.  Pregnancy with Paroxysmal Nocturnal Hemoglobinuria: A Case Series with Review of the Literature.

Authors:  Yara Mohammad Al-Dosari; Hazza Al-Zahrani; Fahad Al-Mohareb; Shahrukh Hashmi
Journal:  Saudi J Med Med Sci       Date:  2021-04-29

6.  Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis.

Authors:  Gérard Socié; Marie-Pierre Caby-Tosi; Jing L Marantz; Alexander Cole; Camille L Bedrosian; Christoph Gasteyger; Arshad Mujeebuddin; Peter Hillmen; Johan Vande Walle; Hermann Haller
Journal:  Br J Haematol       Date:  2019-02-15       Impact factor: 6.998

Review 7.  Generalized pulp canal obliteration in a patient on long-term glucocorticoids: a case report and literature review.

Authors:  Ban Jiandong; Zhang Yunxiao; Wang Zuhua; Hou Yan; Geng Shuangshuang; Li Junke; Wang Hongwei; Xu Hua
Journal:  BMC Oral Health       Date:  2022-08-15       Impact factor: 3.747

8.  Polymorphism of the ABO gene associate with thrombosis risk in patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Zhangbiao Long; Yali Du; Hongmin Li; Bing Han
Journal:  Oncotarget       Date:  2017-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.